GlassScriptPhysician profile
Haley Laymance
NPI 1013151539
$1,382.70
in general payments reported to CMS, 2019-2025
26 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $216 · 2023: $341 · 2024: $431 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,166.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $231.37 | 2024-2025 | Restrata Wound Matrix |
| Kerecis Limited | $177.40 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Teleflex LLC | $116.64 | 2023 | Quikclot |
| Janssen Pharmaceuticals, INC | $75.76 | 2022-2023 | Xarelto |
| Ethicon US, LLC | $75.57 | 2022-2024 | Echelon; Endopath, Surgicel Nu-Knit, Vistaseal |
| Vertex Pharmaceuticals Incorporated | $70.44 | 2025 | |
| Atricure, INC. | $69.13 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Integra Lifesciences Corporation | $58.25 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Octapharma USA, INC. | $50.25 | 2024 | Balfaxar |
| Takeda Pharmaceuticals U.S.A., INC. | $47.12 | 2022 | |
| Tela Bio, INC. | $40.38 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Convatec INC. | $39.30 | 2024 | |
| La Jolla Pharmaceutical Company | $37.20 | 2024-2025 | Giapreza |
| Abbvie INC. | $33.88 | 2024 | |
| Avita Medical Americas, LLC | $33.76 | 2025 | Permeaderm, Recell, Cohealyx |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $31.94 | 2023 | Floseal |
| Zimmer Biomet Holdings, INC. | $27.38 | 2023 | Ribfix Blu Advantage |
| Cerus Corporation | $24.53 | 2023 | Intercept Blood System For Platelets |
| Ambu INC. | $21.04 | 2022 | |
| Abbott Laboratories | $20.37 | 2024 | I-Stat |
| Smith+Nephew, INC. | $19.11 | 2025 | Oasis |
| Aroa Biosurgery Incorporated | $18.01 | 2025 | |
| Sanara Medtech INC. | $16.71 | 2022 | |
| Riggs Hospital Supplies, INC. | $16.39 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $15.59 | 2023 | Andexxa |
| Kowa Pharmaceuticals America, INC. | $15.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Laymance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.